Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: A practice guideline

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 4, 2003, Pages 930-942

  Wong, Rebecca K S ^a   Malthaner, Richard A ^b   Zuraw, Lisa ^c   Rumble, R Bryan ^c   Maroun, Jean ^d   Agboola, O ^e   Citron, M ^e   Cummings, B ^e   DeNardj, F G ^e   Earle, C ^e   Figueredo, A ^e   Fine, S ^e   Fisher, B ^e   Germond, C ^e   Jonker, D ^e   Khoo, K ^e   Kocha, W ^e   Lethbridge, M ^e   Lofters, W ^e   McLeod, R ^e   Moore, M ^e   Tandan, V ^e   more..

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d OTTAWA REGIONAL CANCER CENTRE   (Canada)

^e NONE

Author keywords

Combined radiotherapy chemotherapy; Esophageal cancer

Indexed keywords

BIOLOGICAL ORGANS; CHEMOTHERAPY; RADIOTHERAPY; TOXICITY; TUMORS;

MORTALITY;

RADIATION EFFECTS;

BLEOMYCIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN; TEGAFUR;

ADENOCARCINOMA; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; ESOPHAGITIS; ESOPHAGUS CARCINOMA; FISTULA; GASTROINTESTINAL CARCINOMA; GASTROINTESTINAL SYMPTOM; HUMAN; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; MEDICAL SOCIETY; MEDLINE; META ANALYSIS; METHODOLOGY; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NAUSEA AND VOMITING; ONCOLOGY; PANCYTOPENIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; RADIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SKIN MANIFESTATION; SPINAL CORD DISEASE; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; STOMATITIS; THROMBOCYTE COUNT; TOXICITY; TREATMENT OUTCOME;

EID: 0037443481     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)04278-5     Document Type: Article

References (48)

1. Tanisada K., Teshima T., Ikeda H., et al. Prognostic factors for patients with esophageal cancer treated with radiation therapy in PCS A preliminary study. Radiat Med. 16:1998;461-468.
2. Patti M.G., Owen D. Prognostic factors in esophageal cancer Surgical factors in esophageal cancer. Surg Oncol Clin North Am. 6:1997;515-531.
3. Sobin L.H., Wittekind C.H. TNM classification of malignant tumors. 6th ed: 2002;Wiley-Liss, New York.
4. Wobst A., Audisio R.A., Colleoni M., et al. Oesophageal cancer treatment Studies, strategies and facts. Ann Oncol. 9:1998;951-962.
5. Earlam R. An MRC prospective randomised trial of radiotherapy versus surgery for operable squamous cell carcinoma of the esophagus. Ann R Coll Surg Engl. 73:1991;8-12.
6. Fok M., McShane J., Law S.Y.K., et al. Prospective randomised study in the treatment of oesophageal carcinoma. Asian J Surg. 17:1994;223-229.
7. Badwe R.A., Sharma V., Bhansall M.S., et al. The quality of swallowing for patients with operable esophageal carcinoma. Cancer. 85:1999;763-768.
8. Daly J.M., Karnell L.H., Menck H.R. National Cancer Data Base report on esophageal carcinoma. Cancer. 78:1996;1820-1828.
9. Coia L.R., Minsky B.D., John M.J., et al. The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus Results of the 1992-1994 Patterns of Care Study. Cancer. 85:1999;2499-2505.
10. Youssef Y., Boyd C., Mercer D., et al. Comparison of the management and outcome of carcinoma of the esophagus in Ontario and the United States The Royal College of Physicians and Surgeons of Canada Annual Meeting (CARO), Vancouver, September 1997. Clin Invest Med. 20:1997;531. (Abstr).
11. Browman G.P., Levine M.N., Mohide E.A., et al. The practice guidelines development cycle A conceptual tool for practice guidelines development and implementation. J Clin Oncol. 13:1995;502-512.
12. Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. Oxford: Update Software.
13. Browman G.P., Cronin L. Standard chemotherapy in squamous cell head and neck cancer What have we learned from randomized trials? Semin Oncol. 21:1994;311-319.
14. Der Simonian R., Laird N. Meta-analysis in clinical trials. Controlled Clin Trials. 7:1986;177-188.
15. Bourhis J., Eschwege F. Radiotherapy-chemotherapy combinations in head and neck squamous cell carcinoma Overview of randomized trials. Anticancer Res. 16:1996;2397-2402.
16. Thomas G. Improved treatment for cervical cancer Concurrent chemotherapy and radiotherapy. N Engl J Med. 340:1999;1198-1200.
17. Stafford S.L., Martenson J.A. Combined radiation and chemotherapy for carcinoma of the anal canal. Oncology. 12:1998;373-377.
18. Browman G.P., Hodson D.I., Mackenzie R.J., et al. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer A systematic review of the published literature with sub-group analysis. Head Neck. 23:2001;579-589.
19. Browman GP, Hodson DI, Mackenzie RJ, et al. Concomitant chemotherapy and radiotherapy in squamous cell head and neck cancer (excluding nasopharynx). ( http://hiru.mcmaster.ca/ccopgi/guidelines/head/cpg5_6af.html ).
20. Pignon J.P., Bourhis J., Domenge C., et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma Three meta-analyses of updated individual data. Lancet. 355:2000;949-955.
21. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials Is blinding necessary? Controlled Clin Trials. 17:1996;1-12.
22. L'Abbé K.A., Detsky A.S., O'Rourke K. Meta-analysis in clinical research. Ann Intern Med. 107:1987;224-233.
23. Wong R. Is combination radiotherapy chemotherapy (RTCT) superior to radiotherapy (RT) alone in the non-surgical management of localized esophageal carcinoma? A meta analysis [Abstract]. Int J Radiat Oncol Biol Phys. 45:(Suppl 1):1999;333.
24. Smith T.J., Ryan L.M., Douglas H.G., et al. Combined chemoradiotherapy vs radiotherapy alone for early stage squamous cell carcinoma of the esophagus A study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys. 42:1998;269-276.
25. Earle J.D., Gelber R.D., Moertel C.G., et al. A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 6:1980;821-826.
26. Zhang Z. Radiation combined with bleomycin for esophageal carcinoma - A randomized study of 99 patients. Clin J Oncol. 6:1984;372-374.
27. Andersen A.P., Berdal P., Edsmyr F., et al. Irradiation, chemotherapy and surgery in esophageal cancer A randomized clinical study. The first Scandinavian trial in esophageal cancer. Radiother Oncol. 2:1984;179-188.
28. Araujo C.M., Souhami L., Gil R.A., et al. A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer. 67:1991;2258-2261.
29. Roussel A., Haegele P., Paillot B., et al. Results of the EORTC-GTCCG phase III trial of irradiation vs irradiation and CDDP in inoperable esophageal cancer [Abstract]. Proc Am Soc Clin Oncol. 13:1994;199. (Abstr).
30. Kaneta T., Takai Y., Nemoto K., et al. Effect of combination chemotherapy with daily low-dose CDDP for esophageal cancer Results of a randomized trial. Jpn J Cancer Chemother. 24:1997;2099-2104.
31. Slabber C.F., Nel J.S., Schoeman L., et al. A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. Am J Clin Oncol. 21:1998;462-465.
32. Cooper J.S., Guo M.D., Herksovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer Long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA. 281:1999;1623-1627.
33. Hukku S., Fernandes P., Vasishta S., et al. Radiation therapy alone and in combination with bleomycin and 5-fluorouracil in advanced carcinoma esophagus. Indian J Cancer. 26:1989;131-136.
34. Kolaric K., Zupanc D., Tometic Z. Radiation alone vs radiation + chemotherapy (ddp + 5FU) in locoregionally advanced esophageal cancer - Preliminary report of a prospective randomized study [Abstract]. Ann Oncol. 1:1990;43. (Abstr).
35. Kolaric K, Zupanc D, Tometic Z. Radiation alone vs radiation+ chemotherapy (DDP+ 5FU) in locoregionally advanced esophageal cancer - preliminary report of a prospective randomized study [Abstract]. Third International Congress on the Neo-adjuvant Chemotherapy, 1991.
36. Kolaric K., Zupanc D., Zivkovic M. Radiation alone vs radiochemotherapy (DDP + 5FU) in locoregionally advanced esophageal cancer Report of a prospective randomized study [Abstract]. Ann Oncol. 3:(Suppl. 5):1992;68.
37. Kolaric K, Zupanc D, Zivkovic M. Chemoradiotherapy vs radiation alone in locoregionally advanced esophageal cancer - Report of a prospective randomized study [Abstract]. Eighth Mediterranean Congress of Chemotherapy, May 24-29, 1992.
38. Kolaric K., Zupanc D., Zivkovic M. Radiation alone vs radiochemotherapy (ddp + 5FU) in locoregionally advanced esophageal cancer - Interim report of a prospective randomized study [Abstract]. Proc Am Soc Clin Oncol. 11:1992;A516.
39. al-Sarraf M., Martz K., Herskovic A., et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer An intergroup study. J Clin Oncol. 15:1997;277-284.
40. Herskovic A., Martz K., al-Sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 326:1992;1593-1598.
41. al-Sarraf M, Martz K, Herskovic A. Superiority of combined chemoradiotherapy to radiotherapy alone in patients with esophageal cancers: Intergroup study [Abstract]. Fourth International Congress on Anti-Cancer Chemotherapy, February, 2-5, 1993.
42. al-Sarraf M., Pajak T., Herskovic A., et al. Progress report of combined chemoradiotherapy (CT-RT) vs radiotherapy (RT) alone in patients (pts) with esophageal cancer An intergroup study [Abstract]. Proc Am Soc Clin Oncol. 12:1993;197. (Abstr).
43. Herskovic A., Martz K., al-Sarraf M., et al. Intergroup esophageal study Comparison of radiotherapy (RT) to radio-chemotherapy combination - A phase III trial [Abstract]. Proc Am Soc Clin Oncol. 10:1991;34.
44. Roussel A., Bleiberg H., Dalesio O., et al. Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate Final results of a controlled clinical trial. Int J Radiat Oncol Biol Phys. 16:1989;67-72.
45. Zhou J.C. [Randomized trial of combined chemotherapy including high dose cisplatin, and radiotherapy for esophageal cancer (Chinese)]. Chung Hua Chung Liu Tsa Chih. 13:1991;291-294.
46. Hishikawa Y., Miura T., Oshitani T., et al. A randomized prospective study of adjuvant chemotherapy after radiotherapy in unresectable esophageal carcinoma. Dis Esophagus. 4:1991;85-90.
47. Hatlevoll R., Hagen S., Hansen H.S., et al. Bleomycin/cis-platin as neoadjuvant chemotherapy before radical radiotherapy in localized, inoperable carcinoma of the esophagus A prospective randomized multicentre study - The second Scandinavian trial in esophageal cancer. Radiother Oncol. 24:1992;114-116.
48. Lu X.J., Miao R.H., Li X.Q. [Combination of selective arterial infusion chemotherapy with radiotherapy in the treatment of advanced esophogeal carcinoma (Chinese)]. Chinese J Clin Oncol. 22:1995;262-265.